A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: The probiotics in preterm infantS (PiPS) trial

Health Technology Assessment

Volumn 20, Issue 66, 2016, Pages vii-83

  Costeloe, Kate ^a,b   Bowler, Ursula ^c   Brocklehurst, Peter ^c,d   Hardy, Pollyanna ^c   Heal, Paul ^c   Juszczak, Edmund ^c   King, Andy ^c   Panton, Nicola ^a   Stacey, Fiona ^a,b   Whiley, Angela ^a   Wilks, Mark ^a,e   Millar, Michael R ^a,e  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTACID AGENT; AZTREONAM; BIFIDOBACTERIUM BREVE EXTRACT; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; ERTAPENEM; IMIPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN; PROBIOTIC AGENT;

ACUTE PANCREATITIS; AFRICAN; AFRICAN CARIBBEAN; ANTEPARTUM HEMORRHAGE; APGAR SCORE; ARTICLE; ARTIFICIAL MILK; BACTEREMIA; BACTERIUM DETECTION; BANGLADESHI; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM INFANTIS; BIFIDOBACTERIUM LONGUM; BIRTH WEIGHT; BLOODSTREAM INFECTION; CAUCASIAN; CAUSE OF DEATH; CESAREAN SECTION; CHILD DEATH; CHORIOAMNIONITIS; COHORT ANALYSIS; COMMENSAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIETARY SUPPLEMENT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ENCEPHALOMALACIA; ENTERIC FEEDING; ENTEROBACTERIACEAE; ENTEROCOCCUS; FECES ANALYSIS; FETUS GROWTH; FORCEPS DELIVERY; GESTATIONAL AGE; HEART RATE; HOSPITAL DISCHARGE; HUMAN; HYDROCEPHALUS; INDIAN; INTENSIVE CARE; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; LUNG DYSPLASIA; LUNG HEMORRHAGE; MATERNAL HYPERTENSION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL COLONIZATION; MICROBIOME; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; OBSERVATIONAL STUDY; PAKISTANI; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PORENCEPHALY; PREMATURE LABOR; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SEPSIS; SHELF LIFE; STAPHYLOCOCCUS; TOXIC EPIDERMAL NECROLYSIS; VAGINAL DELIVERY; CLINICAL TRIAL; MORTALITY; MULTICENTER STUDY; NEONATAL INTENSIVE CARE UNIT; NEWBORN;

BIFIDOBACTERIUM BREVE; DOUBLE-BLIND METHOD; ENTEROCOLITIS, NECROTIZING; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; PROBIOTICS; SEPSIS;

EID: 84988515699     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta20660     Document Type: Article

References (100)

1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63-71. http://dx.doi.org/10.1016/S0022-3476(96)70191-9
2. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368:1271-83. http://dx.doi.org/10.1016/S0140-6736(06)69525-1
3. Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005;115:696. http://dx.doi.org/10.1542/peds.2004-0569
4. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-64. http://dx.doi.org/10.1056/NEJMra1005408
5. Walsh MC, Kliegman RM. Necrotising enterocolitis: treatment based on staging criteria. Pediat Clin North Am 1986; 33:179-201.
6. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999;28:19-25. http://dx.doi.org/10.1097/00005176-199901000-00007
7. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P. Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1999;80:F167-73. http://dx.doi.org/10.1136/fn.80.3.F167
8. Sakata H, Yoshioka H, Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr 1985;144:186-90. http://dx.doi.org/10.1007/BF00451911
9. Schwiertz A, Gruhl B, Lobnitz M, Michel P, Radke M, Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 2003;54:393-9. http://dx.doi.org/10.1203/01.PDR.0000078274.74607.7A
10. Duffy LC. Interactions mediating bacterial translocation in the immature intestine. J Nutr 2000;130:432S-6S.
11. Walker WA. Role of nutrients and bacterial colonization in the development of intestinal host defense. J Pediatr Gastroenterol Nutr 2000;30(Suppl. 2):2-7. http://dx.doi.org/10.1097/00005176-200000002-00002
12. Kohler H, McCormick BA, Walker WA. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 2003;36:175-85. http://dx.doi.org/10.1097/00005176-200302000-00005
13. Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008;32:127-37. http://dx.doi.org/10.1053/j.semperi.2008.01.006
14. Claud EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 2001;15:1398-403. http://dx.doi.org/10.1096/fj.00-0833hyp
15. Mai V, Young CM, Ukhanova M, Wang X, Sun Y, Casella G, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLOS ONE 2011;6:e20647. http://dx.doi.org/10.1371/journal.pone.0020647
16. Stewart CJ, Marrs ECL, Magorrian S, Nelson A, Lanyon C, Perry JD, et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr 2012;101:1121-7. http://dx.doi.org/10.1111/j.1651-2227.2012.02801.x
17. Mai V, Torrazza RM, Ukhanova M, Wang X, Sun Y, Li N. Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLOS ONE 2013;8:e52876. http://dx.doi.org/10.1371/journal.pone.0052876
18. Food and Agriculture Organization of the United Nations (FAO)/World Health Organization. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. FAO Food and Nutrition Paper 85. 2001. URL: www.fao.org/3/a-a0512e.pdf (accessed 25 August 2016).
19. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8. http://dx.doi.org/10.1159/000063096
20. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115:1-4.
21. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6. http://dx.doi.org/10.1016/j.jpeds.2005.03.054
22. Samanta M, Sarkar M, Ghosh P, Ghosh JK, Sinha MK, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009;55:128-31. http://dx.doi.org/10.1093/tropej/fmn091
23. Lin H-C, Hsu C-H, Chen H-L, Chung M-Y, Hsu J-F, Lien R-I, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008;122:693-700. http://dx.doi.org/10.1542/peds.2007-3007
24. Neu J, Caicedo R. Probiotics: protecting the intestinal ecosystem? J Pediatr 2005;147:143-6. http://dx.doi.org/10.1016/j.jpeds.2005.05.033
25. Kliegman RM, Willoughby RE. Prevention of necrotizing enterocolitis with probiotics. Pediatrics 2005; 115:171-2.
26. Bell EF. Preventing necrotizing enterocolitis: what works and how safe? Pediatrics 2005;115:173-4.
27. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007;369:1614-20. http://dx.doi.org/10.1016/S0140-6736(07)60748-X
28. Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, et al. Enteral feeding of premature neonates with Saccharomyces boulardii. Early Hum Dev 2003;74:89-96. http://dx.doi.org/10.1016/S0378-3782(03)00090-2
29. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J. Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010;125:1068-70. http://dx.doi.org/10.1542/peds.2009-2151
30. AlFaleh KM, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Sys Rev 2008;1:CD005496. http://dx.doi.org/10.1002/14651858.cd005496.pub2
31. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921-30. http://dx.doi.org/10.1542/peds.2009-1301
32. AlFaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Sys Rev 2011;3:CD005496. http://dx.doi.org/10.1002/14651858.cd005496.pub3
33. Soll RF. Probiotics: are we ready for routine use? Pediatrics 2010;125:1071-2. http://dx.doi.org/10.1542/peds.2010-0643
34. Mihatsch WA, Braegger CP, Decsic T, Kolacek S, Lanzinger H, Mayer B, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 2012;31:6e15.
35. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Sys Rev 2014;4:CD005496. http://dx.doi.org/10.1002/ebch.1976
36. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010;98:156-63. http://dx.doi.org/10.1159/000280291
37. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011;65:434-9. http://dx.doi.org/10.1038/ejcn.2010.278
38. Braga TD, Pontes da Silva GA, Cabral de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birthweight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2011;93:81-6. http://dx.doi.org/10.3945/ajcn.2010.29799
39. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Jaime A, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012;130:e1113-20. http://dx.doi.org/10.1542/peds.2011-3584
40. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013;98:F5-9. http://dx.doi.org/10.1136/archdischild-2011-300435
41. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013;32:1055-62. http://dx.doi.org/10.1542/peds.2013-1339
42. Oncel MY, Sari FN, Arayici S, Guzoglu N, Erdeve O, Uras N, et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2014;99:F110-15. http://dx.doi.org/10.1136/archdischild-2013-304745
43. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial Arch Dis Child 1997;76:F101-7. http://dx.doi.org/10.1136/fn.76.2.F101
44. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3:197-202. http://dx.doi.org/10.1016/S1201-9712(99)90024-3
45. Luoto R, Matomäki J, Isolauri E, Lehtonen L. Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG. Acta Paediatr 2010;99:1135-8. http://dx.doi.org/10.1111/j.1651-2227.2010.01795.x
46. Hunter C, Dimaguila MAVT, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ, et al. Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis. BMC Pediatrics 2012;12:142. http://dx.doi.org/10.1186/1471-2431-12-142
47. Bonsante F, Iacobelli S, Gouyon J-B. Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol 2013; 30:41-6.
48. Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr 2014;164:980-5. http://dx.doi.org/10.1016/j.jpeds.2013.11.025
49. Manzoni P, Lista G, Gallo E, Marangione P, Priolo C, Fontana P, et al. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev 2011;87S:S35-8. http://dx.doi.org/10.1016/j.earlhumdev.2011.01.036
50. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004;38:457-8. http://dx.doi.org/10.1097/00005176-200404000-00017
51. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115:178-81.
52. Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y, et al. Bifidobacterium septicaemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 2010;156:679-81. http://dx.doi.org/10.1016/j.jpeds.2009.11.041
53. Jenke A, Ruf E-M, Hoppe T, Heldmann M, Stefan W. Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Arch Dis Child Fetal Neonatal Ed 2012;97:F217-18. http://dx.doi.org/10.1136/archdischild-2011-300838
54. Murguia-Peniche T, Mihatsch WA, Zegarra J, Supapannachart S, Ding Z-Y, Neu J. Intestinal mucosal defense system, part 2. Probiotics and prebiotics. Pediatrics 2013;162:S64-71. http://dx.doi.org/10.1016/j.jpeds.2012.11.055
55. Li Y, Shimizu T, Hosaka A, Kaneko N. Ohtsuka Y, Yamashiro Y. Effects of Bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Pediatr Int 2004;46:509-15. http://dx.doi.org/10.1111/j.1442-200x.2004.01953.x
56. Chrzanowska-Liszewska D, Seliga-Siwecka J, Kornacka MK. The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial. Early Hum Dev 2012;88:57-60. http://dx.doi.org/10.1016/j.earlhumdev.2011.07.002
57. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-9. http://dx.doi.org/10.1016/S0140-6736(08)60207-X
58. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 2002;110:285-91. http://dx.doi.org/10.1542/peds.110.2.285
59. Llanos AR, Moss ME, Pinzòna MC, Dye T, Sinkin RA, Kendiga JW. Epidemiology of neonatal necrotising enterocolitis: a population based study. Paediatr Perinatal Epidemiol 2002;16:342-9. http://dx.doi.org/10.1046/j.1365-3016.2002.00445.x
60. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008;32:70-82. http://dx.doi.org/10.1053/j.semperi.2008.01.004
61. Underwood MA, Kalanetra KM, Bokulich NA, Lewis ZT, Mirmiran M, Tancredi DJ, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatrics 2013;163:1585-91. http://dx.doi.org/10.1016/j.jpeds.2013.07.017
62. Ishizeki S, Sugita M, Takata M, Yaeshima T. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration. Anaerobe 2013;23:38-44. http://dx.doi.org/10.1016/j.anaerobe.2013.08.002
63. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012;47:241-8. http://dx.doi.org/10.1016/j.jpedsurg.2011.09.064
64. Costeloe KL, Jesudass R, Al Nakib L, Whiley A, Wilks M, Millar MR. The early administration of Bifidobacterium breve strain BBG to very low birthweight infants: a pilot study. Pediatr Res 2004;55:2802.
65. Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr 2005;94(Suppl. 449):100-5. http://dx.doi.org/10.1080/08035320510043637
66. Yee WH, Soraisham AS, Shah VS, Aziz K, Yoon W, Lee SK. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants. Pediatrics 2012;129:e298-304.
67. European Parliament. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. Article 1. Brussels: European Parliament; 2001.
68. Costeloe K, Bowler U, Brocklehurst P, Hardy P, Heal P, Juszczak E, et al. PiPS: Trial of Probiotic Administered Early to Prevent Infection and Necrotising Enterocolitis. Protocol. 2012. URL: www.nets.nihr.ac.uk/__data/assets/pdf_file/0012/51213/PRO-05-501-04.pdf (accessed 25 August 2016).
69. British Society for Antimicrobial Chemotherapy (BSAC). BSAC Methods for Antimicrobial Susceptibility Testing. URL: http://bsac.org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013_final1.pdf (accessed 25 August 2016).
70. Fujimoto J, Tanigawa K, Kudo Y, Makino H, Watanabe K. Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide. J Appl Microbiol 2011;110:209-17. http://dx.doi.org/10.1111/j.1365-2672.2010.04873.x
71. Parry G, Tucker J, Tarnow-Mordi W. CRIB II: an update of the clinical risk for babies score. Lancet 2003;361:1789-91. http://dx.doi.org/10.1016/S0140-6736(03)13397-1
72. Jobe AH, Bancalari E. NICHD/NHLBI/ORD workshop summary: bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. http://dx.doi.org/10.1164/ajrccm.163.7.2011060
73. Abrahamsson TR, Rautava S, Moore AM, Neu J, Sherman PM. The time for a confirmative necrotizing enterocolitis probiotics prevention trial in the extremely low birth weight infant in North America is now! J Pediatr 2014;165:389-94. http://dx.doi.org/10.1016/j.jpeds.2014.05.012
74. Garland SM, Tobin JM, Pirotta M, Tabrizi SN, Opie G, Donath S, et al. The ProPrems trial:investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis 2011;11:210-19. http://dx.doi.org/10.1186/1471-2334-11-210
75. McGee R, O’Connor PM, Russell D, Dempsey EM, Ryan AC, Ross PR, et al. Prolonged faecal excretion following a single dose of probiotic in low birth weight infants. Acta Paediatr 2010;99:1587-8. http://dx.doi.org/10.1111/j.1651-2227.2010.01878.x
76. Gordon PV, Swanson JR, Attridge JT, Clark R. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell’s criteria? J Perinatol 2007;27:661-71. http://dx.doi.org/10.1038/sj.jp.7211782
77. BOOST-II UK (Benefits of Oxygen Saturation Targeting) Trial. Protocol and Handbook. Oxford:National Perinatal Epidemiology Unit; 2011. URL: https://www.npeu.ox.ac.uk/downloads/files/boost/BOOSTII-Protocol-Version-3-Nov-2011.pdf (accessed 25 August 2016).
78. Ventura M, Turroni F, Motherway MO, MacSharry J, van Sinderen D. Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends Microbiol 2012;20:467-76. http://dx.doi.org/10.1016/j.tim.2012.07.002
79. Kline KA, Falker S, Dahlberg S, Normark S, Henriques-Normark B. Bacterial adhesins in host-microbe interactions. Cell Host Microbe 2009;5:580-92. http://dx.doi.org/10.1016/j.chom.2009.05.011
80. Krachler AM, Orth K. Targeting the bacteria-host interface: strategies in anti-adhesion therapy. Virulence 2013;4:284-94. http://dx.doi.org/10.4161/viru.24606
81. Motherway MO, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci USA 2011;108:11217-22. http://dx.doi.org/10.1073/pnas.1105380108
82. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human mucus binding protein. Proc Natl Acad Sci USA 2009;106:17193-8. http://dx.doi.org/10.1073/pnas.0908876106
83. Kalia YN, Nonato LB, Lund CH, Guy RH. Development of skin barrier function in premature infants. J Invest Dermatol 1998;111:320-6. http://dx.doi.org/10.1046/j.1523-1747.1998.00289.x
84. Hickey L, Garland SM, Jacobs SE, O’Donnell CPF, Tabrizi SN. Cross-colonization of infants with probiotic organisms in a neonatal unit. J Hosp Infect 2014;88:226e-9. http://dx.doi.org/10.1016/j.jhin.2014.09.006
85. Battersby C, Santhakumaran S, Modi N, Costeloe K. Incidence and outcomes of severe necrotising enterocolitis in infants less than 32 weeks gestation: a prospective population study. Arch Dis Child 2014;99(Suppl. 2):A38. http://dx.doi.org/10.1136/archdischild-2014-307384.112
86. Gibson MK, Pesesky MW, Dantas G. The yin and yang of bacterial resilience in the human gut microbiota. J Mol Biol 2014;426:3866-76. http://dx.doi.org/10.1016/j.jmb.2014.05.029
87. Chou I-C, Kuo H-T, Chang J-S, Wu S-F, Chiu H-Y, Su B-H, et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatrics 2010;156:393-6. http://dx.doi.org/10.1016/j.jpeds.2009.09.051
88. Neonatal Data Analysis Unit. Neonatal Specialist Care in England: Report on Mortality in 2009. London: Neonatal Data Analysis Unit; 2010. URL: www1.imperial.ac.uk/resources/E8F81103-48A7-44D4-A914-424EFF22470F/ndaureportmortality2009.pdf (accessed 1 March 2016).
89. Madan JC, Salari RC, Saxena D, Davidson L, O’Toole GA, Moore JH, et al. Gut microbial colonisation in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2012;97:F456-62. http://dx.doi.org/10.1136/fetalneonatal-2011-301373
90. Carlisle EM, Morowitz MJ. The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr 2013;25:382-7. http://dx.doi.org/10.1097/MOP.0b013e3283600e91
91. Jeurink PV, van Bergenhenegouwen J, Jiménez E, Knippels LMJ, Fernández L, Garssen J, et al. Human milk: a source of more life than we imagine. Benef Microbes 2013;4:17-30. http://dx.doi.org/10.3920/BM2012.0040
92. Cilieborg MS, Boye M, Sangild PT. Bacterial colonization and gut development in preterm neonates. Early Human Dev 2012;88:S41-9. http://dx.doi.org/10.1016/j.earlhumdev.2011.12.027
93. Neal MD, Sodhi CP, Dyer M, Afrazi B, Richardson WM, Beer-Stolz D, et al. A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis. J Immunol 2013;190:3541-51. http://dx.doi.org/10.4049/jimmunol.1202264
94. MacDorman MF, Mathews TJ, Mohangoo AD, Zeitlin J. International comparisons of infant mortality and related factors: United States and Europe, 2010. National Vital Statistics Reports 2014; 63:1-7.
95. Zeitlin J, Mohangoo AD, Delnord M, Cuttini M. The second European Perinatal Health Report:documenting changes over 6 years in the health of mothers and babies in Europe. Epidemiol Community Health 2013;67:983-5. http://dx.doi.org/10.1136/jech-2013-203291
96. Deshpande G, Rao SC, Keil AD, Patole SK. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Medicine 2011;9:92-104. http://dx.doi.org/10.1186/1741-7015-9-92
97. Montgomery-Taylor S, Emery F, Anthony M. Eighteen months of ‘Matching Michigan’ at a UK neonatal intensive care unit. Pediatr Infect Dis J 2014;32:565-7. http://dx.doi.org/10.1097/INF.0b013e3182868389
98. Lee SK, Shah PS, Singhal N, Aziz K, Synnes A, McMillan D, et al. Association of a quality improvement program with neonatal outcomes in extremely preterm infants: a prospective cohort study CMAJ 2014;186:E485-94. http://dx.doi.org/10.1503/cmaj.140399
99. Battersby C, Santhakumaran S, Upton M, Ladbone L, Birch J, Modi N. The impact of a regional care bundle on maternal breast milk use in preterm infants: outcomes of the East of England quality improvement programme. Arch Dis Child Fetal Neonatal Ed 2014;99:F395-40. http://dx.doi.org/10.1136/archdischild-2013-305475
100. Imperial College. Neonatal Data Analysis Unit. URL: www1.imperial.ac.uk/departmentofmedicine/divisions/infectiousdiseases/paediatrics/neonatalmedicine/ndau/ (accessed 1 March 2016).